An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Chen, Christine I. [1 ]
Paul, Harminder [1 ]
Snitzler, Susi [1 ]
Le, Lisa W. [2 ]
Wei, Ellen Nong [1 ]
Lau, Anthea [2 ]
Johnston, James B. [3 ]
Gibson, Spencer B. [4 ]
Queau, Michelle L. [4 ]
Trudel, Suzanne [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[3] Canc Care Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
[4] Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
    Tefferi, A
    Li, CY
    Reeder, CB
    Geyer, SM
    Allmer, C
    Levitt, R
    Michalak, JC
    Addo, F
    Krook, JE
    Witzig, TE
    Schaefer, PL
    Mailliard, JA
    LEUKEMIA, 2001, 15 (08) : 1171 - 1175
  • [42] A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
    A Tefferi
    C-Y Li
    CB Reeder
    SM Geyer
    C Allmer
    R Levitt
    JC Michalak
    F Addo
    JE Krook
    TE Witzig
    PL Schaefer
    JA Mailliard
    Leukemia, 2001, 15 : 1171 - 1175
  • [43] Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Kimby, E
    Bjorkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Merup, M
    Petrescu, A
    Tullgren, O
    Waldmann, H
    Mellstedt, H
    Osterborg, A
    BLOOD, 2001, 98 (11) : 772A - 772A
  • [44] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [45] 2-CHLORODEOXYADENOSINE (2-CDA) ACTIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    SAVEN, A
    LEMON, RH
    KOSTY, M
    BEUTLER, E
    PIRO, LD
    BLOOD, 1993, 82 (10) : A445 - A445
  • [46] Results of a phase II multicenter study of obinutuzumab plus bendamustine in pts with previously untreated chronic lymphocytic leukemia (CLL).
    Sharman, Jeff Porter
    Yimer, Habte Aragaw
    Boxer, Michael
    DiBella, Nicholas
    Babu, Sunil
    Li, Jia
    Mun, . . . Yong Jun
    Skettino, Sandra L.
    Danilov, Alexey Valeryevich
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] A Phase I Study of Lenalidomide in Combination with Fludarabine-Rituximab in Previously Untreated CLL/SLL.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    Hochberg, Ephraim P.
    Mikler, Evgeny
    Dalton, Virginia
    Reynolds, Hazel
    Romano, Jennifer
    Werner, Lillian
    Thompson, Christina
    McDonough, Sean
    Ritz, Jerome
    Neuberg, Donna
    Freedman, Arnold S.
    BLOOD, 2009, 114 (22) : 1330 - 1331
  • [48] Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia
    Sharman, Jeff P.
    Burke, John M.
    Yimer, Habte A.
    Boxer, Michael A.
    Babu, Sunil
    Li, Jia
    Mun, Yong
    Danilov, Alexey V.
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 791 - 800
  • [49] A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*
    Chen, Christine I.
    Paul, Harminder
    Le, Lisa W.
    Wei, Ellen N.
    Snitzler, Susi
    Wang, Trina
    Levina, Olga
    Kakar, Sumeet
    Lau, Anthea
    Queau, Michelle
    Johnston, James B.
    Smith, Deborah A.
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 92 - 100
  • [50] Lenalidomide and Dexamethasone Combination in Patients with Chronic Lymphocytic Leukemia (CLL) Relapsing or Resistant to Treatment (LENDEX-LLC-09): A Gene Expression Profiling Study
    Puiggros, Anna
    Abrisqueta, Pau
    Nonell, Lara
    Bodalo, Marta
    Puigdecanet, Eulalia
    Jose Terol, Maria
    Delgado, Julio
    Escoda, Lourdes
    Blanco, Gonzalo
    Serrano, Sergi
    Bosch, Francesc
    Espinet, Blanca
    BLOOD, 2014, 124 (21)
12345